FDA/FTC's Hot Ticket: Biosimilar Workshop On How To Boost Market, From Education To Lawsuits

 
• By Brenda Sandburg
theater audience watching a performance
FDA/FTC biosimilars workshop draws large crowd

More from Biosimilars

More from Biosimilars & Generics